CIK 0000939767
- Large accelerated filer
EXELIXIS, INC.
Sign in to watch- Ticker
- EXEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jan 1
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043257395
- Phone
- +1 650-837-7000
- Business address
- 1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
- Former names
- EXELIXIS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-18 | Senner Christopher J. EVP and CFO | Sale | −34,901 | $50.00 | $1.7M | 952,317 |
| 2026-05-15 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −40,892 | $51.10 | $2.1M | 987,218 |
| 2026-02-26 | Senner Christopher J. EVP and CFO | Grant or award | +52,018 | 1,028,110 | ||
| 2026-02-17 | Senner Christopher J. EVP and CFO | Sale | −30,617 | $43.67 | $1.3M | 976,092 |
| 2026-02-15 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −35,870 | $43.92 | $1.6M | 1,006,709 |
| 2026-02-13 | Senner Christopher J. EVP and CFO | Sale | −34,278 | $43.00 | $1.5M | 1,042,579 |
| 2026-01-15 | Senner Christopher J. EVP and CFO | Grant or award | +149,474 | 1,117,316 | ||
| 2026-01-15 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −40,459 | $45.23 | $1.8M | 1,076,857 |
| 2025-05-16 | Senner Christopher J. EVP and CFO | Exercise or conversion | +100,000 | $18.80 | $1.9M | 1,067,842 |
| 2025-05-16 | Senner Christopher J. EVP and CFO | Sale | −100,000 | $46.00 | $4.6M | 967,842 |
| 2025-05-16 | Senner Christopher J. EVP and CFO | Exercise or conversion · Option (right to buy) | −100,000 | 0 | ||
| 2025-05-15 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −41,422 | $44.65 | $1.8M | 967,842 |
| 2025-03-31 | Senner Christopher J. EVP and CFO | Grant or award | +170,009 | 1,009,264 | ||
| 2025-02-26 | Senner Christopher J. EVP and CFO | Grant or award | +59,648 | 839,255 | ||
| 2025-02-24 | Senner Christopher J. EVP and CFO | Exercise or conversion | +29,314 | $18.80 | $551K | 808,921 |
| 2025-02-24 | Senner Christopher J. EVP and CFO | Sale | −29,314 | $36.14 | $1.1M | 779,607 |
| 2025-02-24 | Senner Christopher J. EVP and CFO | Exercise or conversion · Option (right to buy) | −29,314 | 100,000 | ||
| 2025-02-15 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −21,591 | $35.00 | $756K | 779,607 |
| 2025-01-16 | Senner Christopher J. EVP and CFO | Grant or award | +132,973 | 837,147 | ||
| 2025-01-16 | Senner Christopher J. EVP and CFO | Shares withheld for taxes | −35,949 | $37.27 | $1.3M | 801,198 |
Page 1 of 3 · 58 trades